tiprankstipranks
Quantum Biopharma (TSE:QNTM)
:QNTM
Canadian Market
QNTM
Quantum Biopharma
RESEARCH TOOLSreports

Quantum Biopharma (QNTM) Stock News & Sentiment

81 Followers
Quantum BioPharma Cleared to Proceed With $700 Million Market Manipulation Lawsuit After Motion to Dismiss Largely Denied
Premium
Company Announcements
Quantum BioPharma Cleared to Proceed With $700 Million Market Manipulation Lawsuit After Motion to Dismiss Largely Denied
12d ago
6K
QNTM
Quantum BioPharma Files FDA IND for Phase 2 Trial of Lucid-MS in Multiple Sclerosis
Premium
Company Announcements
Quantum BioPharma Files FDA IND for Phase 2 Trial of Lucid-MS in Multiple Sclerosis
13d ago
6K
QNTM
Quantum BioPharma Taps Allucent for Phase 2 Trial of Novel MS Drug Lucid-MS
Premium
Company Announcements
Quantum BioPharma Taps Allucent for Phase 2 Trial of Novel MS Drug Lucid-MS
15d ago
6K
QNTM
Quantum BioPharma Posts Strong 2025 Results, Extends Cash Runway and Advances MS and Alcohol Health Programs
Premium
Company Announcements
Quantum BioPharma Posts Strong 2025 Results, Extends Cash Runway and Advances MS and Alcohol Health Programs
18d ago
6K
QNTM
Quantum BioPharma Taps MS Expert to Lead Phase 2 Trial of Lucid-MS
Premium
Company Announcements
Quantum BioPharma Taps MS Expert to Lead Phase 2 Trial of Lucid-MS
19d ago
6K
QNTM
Is QNTM a Buy, Before Earnings?
Premium
Pre-Earnings
Is QNTM a Buy, Before Earnings?
21d ago
QNTM
Quantum BioPharma Wins Peer-Reviewed Validation for Unbuzzd Alcohol-Relief Supplement
Premium
Company Announcements
Quantum BioPharma Wins Peer-Reviewed Validation for Unbuzzd Alcohol-Relief Supplement
22d ago
6K
QNTM
More TSE:QNTM News >

QNTM News on the Web

Quantum BioPharma Cleared to Proceed With $700 Million Market Manipulation Lawsuit After Motion to Dismiss Largely Denied
TipRanks News
Neutral
Quantum BioPharma Files FDA IND for Phase 2 Trial of Lucid-MS in Multiple Sclerosis
TipRanks News
Bullish
Quantum BioPharma submits Lucid-21-302 new drug application to the FDA
TipRanks News
Neutral
Quantum BioPharma Advances Multiple Sclerosis Pipeline: IND Submission for Lucid-MS Targets Global Market Opportunity
Market Chameleon
Neutral
Quantum BioPharma Advances Multiple Sclerosis Pipeline with IND Submission for Lucid-MS Phase 2 Trial
Market Chameleon
Neutral
Quantum BioPharma Taps Allucent for Phase 2 Trial of Novel MS Drug Lucid-MS
TipRanks News
Neutral
Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial
TipRanks News
Bullish
Quantum Biopharma Strengthens Balance Sheet as Cash Position Supports Growth Through 2028
Market Chameleon
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:QNTM’s Media Buzz Sentiment?
Currently, no data Available
What is TSE:QNTM’s weekly average amount of articles?
Currently, no data Available
What is TSE:QNTM’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TXTMProText Mobility
STAAStaar Surgical
ALLOAllogene Therapeutics
REPLReplimune Group
IVVDInvivyd
Showing the stocks with the most bullish news sentiment over the past week